Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis

Schizophrenia Research

Volumn 135, Issue 1-3, 2012, Pages 175-180

  Whitford, Thomas J ^a,b   Wood, Stephen J ^a,c   Yung, Alison ^a   Cocchi, Luca ^a,d   Berger, Gregor ^a   Shenton, Martha E ^b   Kubicki, Marek ^b   Phillips, Lisa ^a   Velakoulis, Dennis ^a   Yolken, Robert H ^e   Pantelis, Christos ^a   McGorry, Patrick ^a   Amminger, G Paul ^a,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Infectious agents; Magnetic resonance imaging; Schizophrenia; Viral load; Voxel based morphometry

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTERIOR CINGULATE; ANTIBODY BLOOD LEVEL; ARTICLE; CEREBELLUM; CONTROLLED STUDY; CUNEUS; EXPOSURE; FEMALE; GRAY MATTER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; THALAMUS; ULTRA HIGH RISK PATIENT; VOXEL BASED MORPHOMETRY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CEREBRAL CORTEX; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84857234581     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.11.003     Document Type: Article

References (50)

1. Amminger G., McGorry P., Berger G., Wade D., Yung A., Phillips L., Harrigan S., Francey S., Yolken R. Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol. Psychiatry 2007, 61:1215-1217.
2. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) 1984, University of Iowa, Iowa City.
3. Ashburner J., Friston K.J. Voxel-based morphometry - the methods. Neuroimage 2000, 11:805-821.
4. Bluhm R.L., Clark C.R., McFarlane A.C., Moores K.A., Shaw M.E., Lanius R.A. Default network connectivity during a working memory task. Hum. Brain Mapp. 2010, 32:1029-1035.
5. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167:261-280.
6. Buka S., Tsuang M., Torrey E., Klebanoff M., Bernstein D., Yolken R. Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry 2001, 58:1032-1037.
7. Cascella N.G., Fieldstone S.C., Rao V.A., Pearlson G.D., Sawa A., Schretlen D.J. Gray-matter abnormalities in deficit schizophrenia. Schizophr. Res. 2010, 120:63-70.
8. Cocchi L., Walterfang M., Testa R., Wood S.J., Seal M.L., Suckling J., Takahashi T., Proffitt T.M., Brewer W.J., Adamson C., Soulsby B., Velakoulis D., McGorry P.D., Pantelis C. Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia. Schizophr. Res. 2009, 115:163-172.
9. Croen K.D., Ostrove J.M., Dragovic L.J., Smialek J.E., Straus S.E. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. N. Engl. J. Med. 1987, 317:1427-1432.
10. Crow T. A re-evaluation of the viral hypothesis: is psychosis the result of retroviral integration at a site close to the cerebral dominance gene?. Br. J. Psychiatry 1984, 145:243-253.
11. Cunningham A.L., Taylor R., Taylor J., Marks C., Shaw J., Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex. Transm. Infect. 2006, 82:164-168.
12. Feinberg I. Efference copy and corollary discharge: implications for thinking and its disorders. Schizophr. Bull. 1978, 4:636-640.
13. Frith C.D. The Cognitive Neuropsychology of Schizophrenia 1992, Lawrence Erlbaum Associates, Hove, UK.
14. Good C.D., Johnsrude I., Ashburner J., Henson R.N.A., Friston K.J., Frackowiak R.S.J. A voxel-based morphometric study of aging in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
15. Haldane M., Cunningham G., Androutsos C., Frangou S. Structural brain correlates of response inhibition in Bipolar Disorder I. J. Psychopharmacol. 2008, 22:138-143.
16. Hall R.C. Global assessment of functioning. A modified scale. Psychosomatics 1995, 36:267-275.
17. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 2011, 68:128-137.
18. Konopaske G., Dorph-Petersen K., Sweet R., Pierri J., Zhang W., Sampson A., Lewis D. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol. Psychiatry 2008, 63:759-765.
19. Law I., Svarer C., Rostrup E., Paulson O.B. Parieto-occipital cortex activation during self-generated eye movements in the dark. Brain 1998, 121(Pt 11):2189-2200.
20. Levy D.L., Holzman P.S., Matthysse S., Mendell N.R. Eye tracking and schizophrenia: a selective review. Schizophr. Bull. 1994, 20:47-62.
21. McGorry P., Yung A., Phillips L., Yuen H., Francey S., Cosgrave E., Germano D., Bravin J., McDonald T., Blair A., Adlard S., Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 2002, 59:921-928.
22. Mednick S.A., Machon R.A., Huttunen M.O., Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 1988, 45:189-192.
23. Mortensen P.B., Pedersen C.B., Westergaard T., Wohlfahrt J., Ewald H., Mors O., Andersen P.K., Melbye M. Effects of family history and place and season of birth on the risk of schizophrenia. N. Engl. J. Med. 1999, 340:603-608.
24. Nelson H. The National Adult Reading Test (NART): Test Manual 1982.
25. O'Reilly R. Viruses and schizophrenia. Aust. N. Z. J. Psychiatry 1994, 28:222-228.
26. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 1962, 10:799-812.
27. Pearce B. Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms. Mol. Psychiatry 2001, 6:634-646.
28. Prasad K., Shirts B., Yolken R., Keshavan M., Nimgaonkar V. Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Mol. Psychiatry 2007, 12(105-113):101.
29. Sauerbrei A., Wutzler P. Serological detection of type-specific IgG to herpes simplex virus by novel ELISAs based on recombinant and highly purified glycoprotein G. Clin. Lab. 2004, 50:425-429.
30. Schretlen D.J., Vannorsdall T.D., Winicki J.M., Mushtaq Y., Hikida T., Sawa A., Yolken R.H., Dickerson F.B., Cascella N.G. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia. Schizophr. Res. 2010, 118:224-231.
31. Smith J.S., Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 2002, 186(Suppl 1):S3-S28.
32. Tanskanen P., Ridler K., Murray G.K., Haapea M., Veijola J.M., Jaaskelainen E., Miettunen J., Jones P.B., Bullmore E.T., Isohanni M.K. Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness. Schizophr. Bull. 2010, 36:766-777.
33. Torrey E.F., Rawlings R., Waldman I.N. Schizophrenic births and viral diseases in two states. Schizophr. Res. 1988, 1:73-77.
34. Torrey E.F., Miller J., Rawlings R., Yolken R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res. 1997, 28:1-38.
35. Torrey E., Leweke M., Schwarz M., Mueller N., Bachmann S., Schroeder J., Dickerson F., Yolken R. Cytomegalovirus and schizophrenia. CNS Drugs 2006, 20:879-885.
36. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
37. van Tricht M.J., Nieman D.H., Bour L.J., Boeree T., Koelman J.H., de Haan L., Linszen D.H. Increased saccadic rate during smooth pursuit eye movements in patients at Ultra High Risk for developing a psychosis. Brain Cogn. 2010, 73:215-221.
38. Whitford T.J., Grieve S.M., Farrow T.F., Gomes L., Brennan J., Harris A.W.F., Gordon E., Williams L.M. Progressive grey matter atrophy over the first 2-3years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage 2006, 32:511-519.
39. Whitford T.J., Farrow T.F., Williams L.M., Gomes L., Brennan J., Harris A.W. Delusions and dorso-medial frontal cortex volume in first-episode schizophrenia: a voxel-based morphometry study. Psychiatry Res. 2009, 172:175-179.
40. Wood S.J., Kennedy D., Phillips L.J., Seal M.L., Yucel M., Nelson B., Yung A.R., Jackson G., McGorry P.D., Velakoulis D., Pantelis C. Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study. Neuroimage 2010, 52:62-68.
41. Yolken R. Viruses and schizophrenia: a focus on herpes simplex virus. Herpes 2004, 11(Suppl 2):83A-88A.
42. Yolken R., Torrey E. Viruses, schizophrenia, and bipolar disorder. Clin. Microbiol. Rev. 1995, 8:131-145.
43. Yolken R., Torrey E. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol. Psychiatry 2008, 13:470-479.
44. Yolken R., Bachmann S., Ruslanova I., Lillehoj E., Ford G., Torrey E., Schroeder J., Rouslanova I. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin. Infect. Dis. 2001, 32:842-844.
45. Yolken R., Dickerson F., Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol. 2009, 31:706-715.
46. Yung A., Phillips L., McGorry P., McFarlane C., Francey S., Harrigan S., Patton G., Jackson H. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br. J. Psychiatry Suppl 1998, 172:14-20.
47. Yung A., Phillips L., Yuen H., Francey S., McFarlane C., Hallgren M., McGorry P. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr. Res. 2003, 60:21-32.
48. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004, 67:131-142.
49. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Olio M., Francey S.M., Cosgrave E.M., Killackey E., Stanford C., Godfrey K., Buckby J. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust. N. Z. J. Psychiatry 2005, 39:964-971.
50. Zhang S., Li C.S. Functional networks for cognitive control in a stop signal task: independent component analysis. Hum. Brain Mapp. 2011, 33:89-104.